Parkside Financial Bank & Trust

Bank

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1455267 SAINT LOUIS, MO

Position in CPRX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$99,708

+$26,468 QoQ

Shares Held

4,027

+28.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Parkside Financial Bank & Trust holds $38,819,782 across 131 Biotechnology names. CPRX ranks #6 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	1,329,164	$36,817,842
2	VRTX	Vertex Pharmaceuticals Inc / Ma	735	$328,206
3	HALO	Halozyme Therapeutics, Inc.	4,890	$316,040
4	TECH	BIO-TECHNE Corp	3,722	$194,511
5	REGN	Regeneron Pharmaceuticals, Inc.	194	$149,891
6	CPRX	Catalyst Pharmaceuticals, Inc. This page	4,027	$99,708
7	MRNA	Moderna, Inc.	1,807	$91,794
8	DNTH	Dianthus Therapeutics, Inc. /DE/	1,050	$88,116

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$99,708	4,027	+28.3%	Shares	Sole	2026-05-13
2025-12-31	$73,240	3,138	+17.6%	Shares	Sole	2026-02-13
2025-09-30	$52,579	2,669	-5.3%	Shares	Sole	2025-10-30
2025-06-30	$61,172	2,819	-0.6%	Shares	Sole	2025-08-07
2025-03-31	$68,797	2,837	+6.9%	Shares	Sole	2025-05-08
2024-12-31	$55,409	2,655	0.0%	Shares	Sole	2025-02-05
2024-09-30	$52,781	2,655	+18.7%	Shares	Sole	2024-11-07
2024-06-30	$34,650	2,237	-16.4%	Shares	Sole	2024-08-05
2024-03-31	$42,639	2,675	+43.6%	Shares	Sole	2024-05-01
2023-12-31	$31,316	1,863	+1311.4%	Shares	Sole	2024-02-01
2023-03-31	$2,188	132	0.0%	Shares	Defined	2023-05-04
2022-12-31	$2,455	132	0.0%	Shares	Defined	2023-02-14
2022-09-30	$1,693	132	—	Shares	Defined	2022-11-01
No filing history on record for this holder in this stock.